Press Releases

Print Page   Print Page       E-mail Page   Email Page       RSS Feeds   RSS       E-mail Alerts  Email Alerts       Financial Tear Sheet  Tear Sheet

Press Releases

Date Title
08/01/18 Alkermes' Corporate Presentation to be Webcast at the 38th Annual Canaccord Genuity Growth Conference
07/26/18 Alkermes Plc Reports Second Quarter 2018 Financial Results
07/19/18 Alkermes to Host Conference Call to Discuss Second Quarter 2018 Financial Results
07/02/18 FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia
06/06/18 Alkermes to Present at Goldman Sachs 39th Annual Global Healthcare Conference
06/06/18 Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program
05/29/18 Alkermes' Corporate Presentation to be Webcast at the Jefferies 2018 Healthcare Conference
05/23/18 Alkermes to Present Data on Depression and Schizophrenia Portfolios at Upcoming American Society of Clinical Psychopharmacology Annual Meeting
05/14/18 Alkermes' Corporate Presentation to be Webcast at the UBS Global Healthcare Conference
05/10/18 Alkermes' Corporate Presentation to be Webcast at the Bank of America Merrill Lynch Health Care Conference
05/04/18 Alkermes Launches Award Program To Support And Advance Central Nervous System Disorders Research
05/03/18 Alkermes to Host Webcast and Conference Call to Discuss ALKS 3831 Development Program
05/02/18 Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank 43rd Annual Health Care Conference
04/30/18 Alkermes to Present Clinical Data at Upcoming American Psychiatric Association Annual Meeting
04/26/18 Alkermes Completes Patient Enrollment in Pivotal Weight Study of ALKS 3831 for Schizophrenia
Displaying 106 - 120 of 795